This study is affiliated to Sino Longitudinal Study on Cognitive Decline, SILCODE. To establish models of normal and pathological cognitive aging.To collect the longitudinal data of SCD population, to study the dynamic changes of brain networks so as to explore the progressive mechanisms of AD on brain networks and to construct a high-precision multi-modal model for early diagnosis.
This study is affiliated to Sino Longitudinal Study on Cognitive Decline, SILCODE. Alzheimer's disease (AD) is the most common cause of dementia, which severely injures multiple domains of cognitive functions in the aging people, bringing heavy burden to the society and families. Studying the cognitive brain damage mechanism of subjective cognitive decline (SCD), the preclinical stage of AD, would provide great opportunities for understanding the pathogenesis of AD and clinical value for early diagnosis and intervention in AD. The project intends to utilize amyloid-PET and FDG-PET for screening and then employ the comprehensive neuropsychological examination combined with multi-modal MRI neuroimaging techniques to study the brain functions and structures of the normal aging and SCD. The imaging data would be analyzed from several levels, including the cognitive dimensions, brain activation patterns, and especially functional and structural networks to establish the models of normal and pathological cognitive aging, which mainly be modulated by frontal-parietal control system. We aim to establish models of normal and pathological cognitive aging. Furthermore, the longitudinal data of SCD population would be collected to study the dynamic changes of brain networks so as to explore the progressive mechanisms of AD on brain networks and to construct a high-precision multi-modal model for early diagnosis
Study Type
OBSERVATIONAL
Enrollment
300
Neuropsychological scale, including mini-mental state examination (MMSE), Montreal cognitive assessment (MoCA), clinical dementia rating scales (CDR) and so on
Department of Neurolgy,Xuanwu Hospital of Capital Medical University
Beijing, Beijing Municipality, China
The altered volume pattern in SCD/SCD-plus with progression.
1. Global grey matter volume change of brain in µm3 2. Regional gray matter volume change of brain in µm3 3. Cerebral cortex thickness change of brain in µm
Time frame: 5 years
The altered DTI pattern in SCD/SCD-plus with progression.
1. Regional fractional anisotropy (FA), measured by diffusion tensor imaging (DTI). 2. Regional mean diffusivity (MD), measured by DTI. 3. Regional radial diffusivity (RD), measured by DTI. 4. Regional axial diffusivity (AxD), measured by DTI.
Time frame: 5 years
The altered functional MRI pattern in SCD/SCD-plus with progression.
Resting state functional MRI blood-oxygen-level-dependent (fMRI BOLD) signal.
Time frame: 5 years
The altered FDG-PET pattern in SCD/SCD-plus with progression.
Global SUVR change of brain of FDG-PET in kBq/ml/MBq/kg.
Time frame: 5 years
The altered AV45-PET pattern in SCD/SCD-plus with progression.
Global SUVR change of brain of AV45-PET in kBq/ml/MBq/kg.
Time frame: 5 years
Genotype of SCD/SCD-plus with progression.
ApoE genotype by blood test.
Time frame: 5 years
AD7c-NTP level of SCD/SCD-plus with progression.
AD7c-NTP level by urine tests.
Time frame: 5 years
Gut microbiota of SCD/SCD-plus with progression.
Gut microbiota level by 16s rDNA sequencing
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: 5 years